Pregnancy Registry in Mali
Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Jun 14, 2024
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Pregnancy Registry in Mali is a study designed to understand how malaria affects pregnancy outcomes in women living in Kalifabougou. Researchers will collect information from women who are either pregnant or able to become pregnant, focusing on their health and the health of their babies. The goal is to gather important data that can help improve care for pregnant women and their children in areas where malaria is common.
To participate in this study, women must be between the ages of 15 and 49, live in or near Kalifabougou, and be willing to visit the health center for regular check-ups during their pregnancy. They should also be able to give their consent to join the study. If a woman is temporarily living in the area or has other health issues that could affect her safety or the study's goals, she may not be eligible. Participants will be asked to share their experiences and health information, which will contribute to a better understanding of pregnancy and malaria.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- Community Census Cohort:
- • 1. Females of childbearing potential or pregnant females.
- • 2. Aged 15 to 49 years.
- • 3. Able to provide verbal individual informed consent.
- Health Facility Cohort:
- • 1. Pregnant females 15 to 49 years and their subsequent offspring.
- • 2. Resides in or in the health catchment area of Kalifabougou and willing to return to the health center for Antenatal Care (ANC) visits.
- • 3. Able to provide written individual informed consent for herself and her future offspring(s).
- Exclusion Criteria:
- Community Census Cohort:
- • 1. Temporary residence in the study area.
- • 2. Other condition(s) that, in the opinion of the investigator, would jeopardize the safety or rights of an individual participating in the study, interfere with the evaluation of the study objectives, or render the participant unable to comply with the protocol.
- Health Facility Cohort:
- • 1. Temporary residence in the study area.
- • 2. Other condition(s) that, in the opinion of the investigator, would jeopardize the safety or rights of an individual participating in the study, interfere with the evaluation of the study objectives, or render the participant unable to comply with the protocol.
About National Institute Of Allergy And Infectious Diseases (Niaid)
The National Institute of Allergy and Infectious Diseases (NIAID) is a key component of the National Institutes of Health (NIH) dedicated to advancing the understanding, prevention, and treatment of infectious and immune-mediated diseases. Through rigorous clinical trials, NIAID aims to foster innovative research that enhances public health and addresses global health challenges, including emerging infectious diseases and allergies. The institute collaborates with various partners, including academic institutions, industry, and international organizations, to translate scientific discoveries into effective therapies and vaccines. NIAID's commitment to high-quality clinical research is integral to improving health outcomes and informing policy decisions in the realm of infectious diseases and immunology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kalifabougou, Région De Koulikoro, Mali
Kalifabougou, , Mali
Patients applied
Trial Officials
Kassoum Kayentao, MD, MPH, PhD
Principal Investigator
Faculté de Médecine Pharmacie d'Odontostomatologie (FMOS)
Peter Crompton, MD, MPH
Principal Investigator
National Institutes of Health (NIH)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported